Pilo Shlomo
SEC insider (Form 3/4/5 filer). CIK 0001903730. Chief Executive Officer at Raphael Pharmaceutical Inc. (RAPH). 1 reported Form 4/5 transaction since Sep 2024; latest on Mar 2, 2025. Located in TEL AVIV-JAFFA, L3.
Companies Pilo Shlomo has filed insider reports for
- Raphael Pharmaceutical Inc. (RAPH): Director, Officer, 10% Owner, Chief Executive Officer
Pilo Shlomo
CIK: 0001903730
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RAPH
Raphael Pharmaceutical Inc.
DirectorOfficer10% Owner